301 related articles for article (PubMed ID: 27330845)
21. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
22. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
23. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
24. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive impairment in Albino mice.
Sharma S; Raj K; Singh S
Drug Chem Toxicol; 2022 Nov; 45(6):2769-2779. PubMed ID: 34674598
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways.
Ongnok B; Prathumsap N; Chunchai T; Pantiya P; Arunsak B; Chattipakorn N; Chattipakorn SC
Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38568417
[TBL] [Abstract][Full Text] [Related]
27. Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice.
Sung PS; Chen PW; Yen CJ; Shen MR; Chen CH; Tsai KJ; Lin CK
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439331
[TBL] [Abstract][Full Text] [Related]
28. Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study.
Argyriou AA; Karteri S; Bruna J; Mariotto S; Simo M; Velissaris D; Kalofonou F; Cavaletti G; Ferrari S; Kalofonos HP
Support Care Cancer; 2022 Feb; 30(2):1807-1814. PubMed ID: 34599664
[TBL] [Abstract][Full Text] [Related]
29. Pifithrin-μ Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
Chiu GS; Maj MA; Rizvi S; Dantzer R; Vichaya EG; Laumet G; Kavelaars A; Heijnen CJ
Cancer Res; 2017 Feb; 77(3):742-752. PubMed ID: 27879267
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-Induced Cognitive Impairment.
Kinsley K; Pritchett W
Clin J Oncol Nurs; 2023 Mar; 27(2):205-208. PubMed ID: 37677835
[TBL] [Abstract][Full Text] [Related]
31. Superoxide induces protein oxidation in plasma and TNF-α elevation in macrophage culture: Insights into mechanisms of neurotoxicity following doxorubicin chemotherapy.
Keeney JT; Miriyala S; Noel T; Moscow JA; St Clair DK; Butterfield DA
Cancer Lett; 2015 Oct; 367(2):157-61. PubMed ID: 26225838
[TBL] [Abstract][Full Text] [Related]
32. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
[TBL] [Abstract][Full Text] [Related]
34. Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review.
Alexander TC; Krull KR
Neurosci Biobehav Rev; 2021 Oct; 129():206-217. PubMed ID: 34352229
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.
John J; Kinra M; Ranadive N; Keni R; Nayak PG; Jagdale RN; Ahmed SM; Raghavendra KV; Mudgal J; Nandakumar K
Sci Rep; 2022 Feb; 12(1):3072. PubMed ID: 35197512
[TBL] [Abstract][Full Text] [Related]
36. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporin A-mediated translocation of HuR improves MTX-induced cognitive impairment in a mouse model via NCOA4-mediated ferritinophagy.
Ding H; Xiang R; Jia Y; Ye J; Xia Z
Aging (Albany NY); 2023 Nov; 15(21):12537-12550. PubMed ID: 37950727
[TBL] [Abstract][Full Text] [Related]
38. [Chemobrain].
Szentmartoni G; Makkos Z; Dank M
Neuropsychopharmacol Hung; 2018 Sep; 20(3):112-116. PubMed ID: 30459288
[TBL] [Abstract][Full Text] [Related]
39. Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment.
Ossorio-Salazar VA; D'Hooge R
Neurosci Biobehav Rev; 2023 Jul; 150():105198. PubMed ID: 37105339
[No Abstract] [Full Text] [Related]
40. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
